-
The mental health apps expected to drive 240% market growth by 2028
The mental health app market is projected to be valued at $9.9 billion by 2028, an increase of about 240 percent from 2021's value of $4.1 billion, according to a report by Vantage Market Research. -
It's time for behavioral health to adopt measurement, says CEO
Measurement-based care has been shown to produce better outcomes than usual standard care, which does not involve measurement. But multiple studies have shown a majority of behavioral health clinicians still do not use measurement-based care. -
HearMe, Ingenovis Health partner to provide nurses with 24/7 mental health support
Text-based mental health support provider HearMe and healthcare staffing firm Ingenovis Health partnered to create a free support system for travel nurses available 24/7. -
Mental health software market to reach $5.6B market value in 2028: 3 key factors driving growth
The mental health software market value is on track to reach $5.6 billion by 2028, led by three industry developments, according to a market research study published Aug. 8. by Facts and Factors. -
Abbott's breakthrough deep brain stimulation treatment: An overview
Abbott's deep brain stimulation device was awarded the FDA's breakthrough device designation for treatment-resistant depression, Abbott said July 27. -
UCLA psychiatrist Smitta Patel to join VyTrac Health's advisory board
Smitta Patel, MD, a psychiatrist at the UCLA Semel Institute for Neuroscience and Human Behavior, is joining VyTrac Health's medical advisory board. -
Neuronetics, Alleviant Health form exclusive partnership
Medical technology company Neuronetics will be the exclusive supplier of transcranial magnetic stimulation equipment used in the mental health treatment network of Arkansas-based Alleviant Health, Neuronetics said July 25. -
4 promising psychiatric medications seeking FDA approval
In clinical trials, four in-development psychiatric drugs show promise for treatment of schizophrenia, postpartum depression and major depressive disorder, MDLinx reported July 21. -
FDA approves Neuronetics' transcranial magnetic stimulation treatment for depression-related anxiety
The FDA has approved Neuronetics' transcranial magnetic stimulation system as a treatment for adults with major depressive disorder, the company said this week. -
AI chatbot app Wysa lands $20M
Wysa, an artificial intelligence digital mental health platform, nabbed $20 million in funding, the company said July 18. -
Best online psychiatry of 2022, per Forbes
Below are Forbes' top five virtual psychiatry platforms, determined considering costs, conditions treated, quality of providers and more, published July 14. -
988 crisis line launch: Are states ready?
The U.S. has seen a broad push for increased mental health resources since the beginning of the COVID-19 pandemic, but staffing and provider counts are still woefully inadequate in some places. -
Nevada program links counselors, police responding to mental health crises
Nevada HHS is using a $3.8 million grant to launch Virtual Crisis Care, a program providing law enforcement with 24/7 access to counselors when responding to mental health crisis calls, law enforcement news source Police1 reported July 7. -
$4M launches Arise, a company that will treat eating disorders virtually
Arise, a mental healthcare company aiming to provide comprehensive virtual care for eating disorders, launched July 11 after raising over $4 million in a seed-funding round. -
Digital mental health companies a 'catastrophe waiting to happen,' warns industry exec
Behavioral health professionals are concerned that for-profit, corporate online behavioral healthcare companies don't adequately train their practitioners and have questionable prescription protocols, liabilities that one industry veteran called "a catastrophe waiting to happen," Kaiser Health News reported July 8. -
Transcorneal electrical stimulation reduces stress in lab rats, study finds
Noninvasive stimulation of the corneal surface in the eyes resulted in "remarkable" antidepressant-like effects and also reduced stress hormones in an animal model of depression, a study published May 27 in Brain Stimulation and June 25 in Annals of the New York Academy of Sciences showed. -
VR device that treats serious mental illness wins FDA breakthrough designation
The FDA designated digital therapeutics company OxfordVR's GameChange virtual reality mental health platform a breakthrough device. -
Headspace unveils workshop series designed for leaders to support employee mental health
Headspace, a popular meditation and mindfulness mobile app, announced its new Leadership Workshop Series, a three-branch program designed to coach leaders on best practices to support mental health in the workplace. -
How Instagram's new features aim to boost teens' mental health
Instagram's to-be-released features will send a notification to teens spending significant amounts of time on the platform to make users more mindful of their time spent on social media, TechCrunch reported June 14. -
Facebook, Instagram sued for 'exploiting young people for profit' amid mental health crisis
Facebook and Instagram parent company Meta Platforms was hit with eight new lawsuits accusing the company of exploiting children and young adults for profit, Fox Business reported June 11.
Page 5 of 50